Drug discovery in prostate cancer mouse models

Area of Science:

• Oncology
• Translational Medicine
• Preclinical Research

Background:

• Mice serve as essential models for human disease and preclinical drug discovery.
• Prostate cancer modeling in mice presents challenges, with many drugs failing in human trials despite success in mice.
• Understanding mouse-human differences is key for effective preclinical research.

Purpose of the Study:

• To evaluate the utility of mouse models in prostate cancer research and drug discovery.
• To identify challenges and unmet needs in using mouse models for human disease translation.
• To provide practical guidelines for optimizing mouse model utilization in drug development.

Main Methods:

• Discussion of interspecies similarities and differences (mouse vs. human).
• Review of existing mouse models for prostate cancer.
• Analysis of practical considerations and limitations in mouse model research.
• Exploration of reasons for drug translation failures from mice to humans.

Main Results:

• Mouse models are valuable tools when utilized with proper planning and guidelines.
• Current limitations include a lack of genetically engineered metastatic models.
• Xenograft models do not adequately represent the immune system's role in metastasis.

Conclusions:

• Despite limitations, mouse models remain indispensable for prostate cancer research and drug discovery.
• Overcoming challenges requires addressing specific model deficiencies and improving research strategies.
• Advancements in technology and communication offer a promising future for mouse modeling in translational oncology.